Showing posts with label platinum-resistant. Show all posts
Showing posts with label platinum-resistant. Show all posts
Friday, January 22, 2010
Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock
"The OVATURE trial is a major multi-center international Phase III clinical trial of orally-administered investigational drug phenoxodiol in combination with carboplatin in women with advanced ovarian cancer resistant or refractory to platinum-based drugs, to determine its safety and effectiveness when used in combination with carboplatin.......The Company expects the final analysis will be performed strictly according to the protocol and now is expected to be completed in the second quarter of 2010"
add your opinions
Carboplatin
,
ovarian cancer
,
Ovature
,
phase 111
,
Phenoxodiol
,
platinum-resistant
,
refractory
,
trial results
Thursday, January 07, 2010
Biotech News & Online Store - Belinostat phase II trial initiated in platinum-resistant ovarian cancer by the Gynecologic Oncology Group (GOG) supported by
The study:
A Phase II evaluation of Belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer.
add your opinions
ovarian
,
platinum-resistant
,
trial
Subscribe to:
Posts
(
Atom
)